Immune-based therapies for prostate cancer

This publication has 56 references indexed in Scilit:

• γδ T cells for immune therapy of patients with lymphoid malignancies
  Blood, 2003
• GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial
  The Prostate, 1999
• FLT3 Ligand Induces the Generation of Functionally Active Dendritic Cells in Mice
  Cellular Immunology, 1997
• In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen
  JNCI Journal of the National Cancer Institute, 1997
• A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate
  International Journal of Cancer, 1995
• Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma
  European Journal Of Cancer, 1994
• Cytokine regulation of eosinophil function
  Clinical Immunology and Immunopathology, 1992
• Direct Gene Transfer into Mouse Muscle in Vivo
  Science, 1990
• Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator
  Nature, 1985
• Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.
  The Journal of Experimental Medicine, 1978